| Financial Year |
March 31 2023 |
| Monetary Funds |
103,745,169.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,000.00 |
| Accounts Receivable |
80,148,720.40 |
| Advances to Suppliers |
10,008,366.35 |
| Other Receivables |
5,330,233.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
191,847,092.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,056,819.08 |
| Total Current Assets |
425,486,663.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,171,687.78 |
| Investment Properties |
-- |
| Fixed Assetes |
772,285,896.97 |
| Under-construction Projects |
25,470,553.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,355,914.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
366,500.00 |
| Deferred Income Tax Assets |
58,211,810.52 |
| Other Non-Current Assets |
4,392,788.14 |
| Sub-Total of Non-Current Assets |
982,386,782.27 |
| Total Assets |
1,407,873,446.26 |
| Short-Term Loans |
248,120,350.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
57,527,612.87 |
| Accounts Payable |
63,299,465.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,558,631.42 |
| Taxes Payable |
1,005,485.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,301,213.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,460,133.07 |
| Other Current Liabilities |
348,475.90 |
| Sub-Total of Current Liabilities |
436,322,165.63 |
| Long-term Loans |
209,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,480,071.68 |
| Deferred Income Tax Liabilities |
3,057,700.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
221,055,726.66 |
| Total Liabilities |
657,377,892.29 |
| Paid-In Capital(Or Share Stock) |
234,750,130.00 |
| Capital Surplus |
235,871,050.52 |
| Surplus Reserve |
41,565,959.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
264,024,542.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
750,495,553.97 |
| Owner's Equity（Stockholder's Equity） |
750,495,553.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,407,873,446.26 |
